Kawin Technology Overview
- Founded
-
2008
- Status
-
Public
- Employees
-
647
- Stock Symbol
-
688687
- Investments
-
2
- Share Price
-
$2.69
- (As of Friday Closing)
Kawin Technology General Information
Description
Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
SHG
Primary Office
- No. 6 Rongjing Street East
- Beijing Economic and Technological Development Zone
- Beijing, 100176
- China
+86 010 0000 0000
Kawin Technology Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.69 | $2.66 | $2.36 - $4.86 | $451M | 170M | 3.6M | $0.10 |
Kawin Technology Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 369,366 | 540,313 | ||
| Revenue | 178,118 | 177,225 | 124,780 | 119,388 |
| EBITDA | 15,895 | 21,412 | 16,674 | 12,503 |
| Net Income | 17,312 | 16,616 | 10,938 | 7,751 |
| Total Assets | 337,727 | 341,654 | 179,419 | 150,428 |
| Total Debt | 458 | 536 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Kawin Technology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kawin Technology Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Desheng Zhou MD | Chairman & General Manager | ||
| Yunde Hou | Founder |
Kawin Technology Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Desheng Zhou MD | Kawin Technology | Chairman & General Manager | 000 0000 |
| Hui Li | Self | Board Member | 000 0000 |
| Liping Zhang | Self | Board Member | 000 0000 |
| Ningning Ma | Self | Board Member | 000 0000 |
| Qingmin Wu | Self | Co-Chairman | 000 0000 |
Kawin Technology Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Kawin Technology Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 11-Jan-2019 | 00000 0000 | 000.00 | Biotechnology | |
| Ginkgo | 03-Aug-2015 | Corporate | Drug Discovery |